| Patents for A61K 31 - Medicinal preparations containing organic active ingredients (785,912) |
|---|
| 06/22/2005 | EP1542904A1 Process for producing metered dose inhaler formulations |
| 06/22/2005 | EP1542768A1 Use of cytokine synthesis inhibitors for the treatment of dry eye disorders |
| 06/22/2005 | EP1542753A1 Pharmaceutical compositions |
| 06/22/2005 | EP1542728A1 Hybrid of itraconazole, cyclosporine or carvedilol with a layered silicate and a process for preparing the same |
| 06/22/2005 | EP1542727A2 Breath freshening and oral cleansing product |
| 06/22/2005 | EP1542719A2 Methods and compositions for control of bone formation via modulation of sympathetic tone |
| 06/22/2005 | EP1542706A1 Poly (potassium and sodium styrene sulfonate), its manufacture and its uses |
| 06/22/2005 | EP1542705A1 Anticoagulant composition |
| 06/22/2005 | EP1542704A1 Method and composition for preventing pain in sickle cell patients |
| 06/22/2005 | EP1542702A2 Methods and compositions for treatment of neurological disorder |
| 06/22/2005 | EP1542700A1 Method for preventing or reducing secondary fractures after hip fracture |
| 06/22/2005 | EP1542699A2 Compounds, compositions, and methods employing same |
| 06/22/2005 | EP1542698A2 Modulation of matrix metalloproteinase (mmp) activity with aldosterone blocker(s) |
| 06/22/2005 | EP1542697A1 Modified release formulations of oxcarbazepine and derivatives thereof |
| 06/22/2005 | EP1542695A1 Pharmaceutical composition for topical delivery of meloxicam comprising an amine or amine as penetration enhancer. |
| 06/22/2005 | EP1542694A1 New spirocondensed quinazolinones and their use as phosphodiesterase inhibitors |
| 06/22/2005 | EP1542692A1 Amino-pyridine, -pyridine and pyridazine derivatives for use as vanilloid receptor ligands for the treatment of pain |
| 06/22/2005 | EP1542691A2 Composition for the treatment of nasopharyngeal carcinoma and use thereof |
| 06/22/2005 | EP1542690A2 Manzamine-producing actinomycetes |
| 06/22/2005 | EP1542689A2 Improved process for hydroxyazapirones |
| 06/22/2005 | EP1542687A1 Small organic molecules that increase the activity of gelatinase a in ocular cells |
| 06/22/2005 | EP1542686A2 Aryl substituted hydantoin compounds and their use as sodium channel blockers |
| 06/22/2005 | EP1542685A1 Triazole derivatives as transforming growth factor (tgf) inhibitors |
| 06/22/2005 | EP1542684A2 Novel pyrazole compounds as transforming growth factor (tgf) inhibitors |
| 06/22/2005 | EP1542683A2 Calcium channel blockers |
| 06/22/2005 | EP1542682A2 Novel inhibitors of ubiquitin isopeptidases |
| 06/22/2005 | EP1542681A2 Use of posaconazole for the treatment of fungal infections |
| 06/22/2005 | EP1542679A1 4-(3,5-dicyanophenoxy) pyrazole derivatives for use as transcriptase modulators in the treatment of i.a. hiv |
| 06/22/2005 | EP1542678A1 1H-1,2,4-TRIAZOLE-3-CARBOXAMIDE DERIVATIVES AS CANNABINOID-CB sb 1 /sb RECEPTOR LIGANDS |
| 06/22/2005 | EP1542677A1 COMBINATIONS OF ATORVASTATIN AND a1, ADRENERGIC RECEPTOR ANTA GONISTS |
| 06/22/2005 | EP1542676A1 Methods of treating benzodiazepine site (bzd-s) associated syndromes using 2' hydroxyflavonoids |
| 06/22/2005 | EP1542675A1 Compounds useful for the inhibition of aldh |
| 06/22/2005 | EP1542674A1 Chondropsin-class antitumor v-atpase inhibitor compounds, compositions and methods of use thereof |
| 06/22/2005 | EP1542673A1 Use of (r)-verapamil for the treatment of abnormal increases in gastrointestinal motility |
| 06/22/2005 | EP1542672A2 R-bambuterol, its preparation and therapeutic uses |
| 06/22/2005 | EP1542671A1 Composition based on triethyl citrate for the treatment of bacterial infections of the skin |
| 06/22/2005 | EP1542670A1 Composition containing arachidonic acid alone or in combination with docosahexaenoic acid for enhancing cognitive abilities |
| 06/22/2005 | EP1542669A1 Leucine-enriched nutritional compositions |
| 06/22/2005 | EP1542668A2 Aripiprazole complex formulation and method |
| 06/22/2005 | EP1542667A2 Ureido substituted benzoic acid compounds and their use for nonsense suppression and the treatment of disease |
| 06/22/2005 | EP1542666A1 Modafinil pharmaceutical compositions |
| 06/22/2005 | EP1542665A1 Method for treating depression and/or anxiety |
| 06/22/2005 | EP1542664A2 Methods and compositions for treatment of macular and retinal disease |
| 06/22/2005 | EP1542663A1 A treatment solution and method for preventing posterior capsular opacification by selectively inducing detachment and/or death of lens epithelial cells |
| 06/22/2005 | EP1542660A1 Sustained released delivery of amphetamine salts |
| 06/22/2005 | EP1542658A1 Pharmaceutical compositions |
| 06/22/2005 | EP1542656A1 Antibiotic product, use and formulation thereof |
| 06/22/2005 | EP1542654A1 Skin photoageing and actinic damage treatment |
| 06/22/2005 | EP1542628A1 Medicinal product packaging |
| 06/22/2005 | EP1542543A1 Hop acids as a replacement for antibiotics in animal feed |
| 06/22/2005 | EP1542531A1 Aqueous fludarabine phosphate composition |
| 06/22/2005 | EP1542528A1 A method of treatment and prophylaxis |
| 06/22/2005 | EP1469856A4 8-heteroaryl xanthine adenosine a sb 2b /sb receptor antagonists |
| 06/22/2005 | EP1461046A4 Fluorinated glucosamine analogs useful for modulating post-translational glycosylations on cells |
| 06/22/2005 | EP1411879A4 A composition and uses therefor for combating hangover |
| 06/22/2005 | EP1383752B1 Deuterated 3-piperidinopropiophenone and medicaments containing said compounds |
| 06/22/2005 | EP1381611B1 Metal substituted non centrosimmetrical phthalocyanine analogues, their preparation and use in photodynamic therapy and in vivo diagnostic |
| 06/22/2005 | EP1372656B1 Pyrazolo[4,3-d]pyrimidinone compounds as cgmp pde inhibitors |
| 06/22/2005 | EP1360187B1 3,7-diazabicyclo(3.3.0)octanes and their use in the treatment of cardiac arrhythmias |
| 06/22/2005 | EP1345933B1 Process for making substituted 8-arylquinolinium benzenesulfonate |
| 06/22/2005 | EP1320523B1 Branched chain amino acid-dependent aminotransferase inhibitors and their use in the treatment of neurodegenerative diseases |
| 06/22/2005 | EP1282619B1 Processes for the preparation of thiazolidinedione derivatives and intermediates |
| 06/22/2005 | EP1272200B1 Divided dose therapies with vascular damaging activity |
| 06/22/2005 | EP1268466B1 Decahydro-isoquinolines |
| 06/22/2005 | EP1263749B1 Taxane anticancer agents |
| 06/22/2005 | EP1233964B1 New use and novel n-azabicyclo-amide derivatives |
| 06/22/2005 | EP1191025B1 Crystals of lansoprazole |
| 06/22/2005 | EP1177200B1 Ligands for metabotropic glutamate receptors |
| 06/22/2005 | EP1173160B1 (e)-styryl sulfone anticancer agents |
| 06/22/2005 | EP1171136B1 Immunomodulating compositions comprising urea derivatives for use in the treatment of inflammatory diseases |
| 06/22/2005 | EP1154774B1 Quinazoline derivatives as angiogenesis inhibitors |
| 06/22/2005 | EP1140273B1 Device for locally delivering a drug in a body cavity |
| 06/22/2005 | EP1131039B1 Use of a substance binding with the peripheral benzodiazepin receptor for treating skin stress |
| 06/22/2005 | EP1100763B1 Diketoacid-derivatives as inhibitors of polymerases |
| 06/22/2005 | EP1100542B1 Peg-urate oxidase conjugates and use thereof |
| 06/22/2005 | EP1082127B1 Succinamide inhibitors of interleukin-1beta converting enzyme |
| 06/22/2005 | EP1062946B1 Preventives and remedies for intestinal mucosal disorder |
| 06/22/2005 | EP1040111B1 Integrin receptor antagonists |
| 06/22/2005 | EP1009411B1 Treatment of sleep apnea |
| 06/22/2005 | EP1007533B1 Bioconjugates and delivery of bioactive agents |
| 06/22/2005 | EP0974363B1 Remedies for drug addiction |
| 06/22/2005 | EP0932416B1 Method and potentiated composition for treating migraine |
| 06/22/2005 | EP0866874B2 Process for the preparation of materials with a high content of isomers of conjugated linoleic acid |
| 06/22/2005 | CN1630818A Diagnostic markers for ischemia |
| 06/22/2005 | CN1630724A Compositions and methods for inhibiting expression of a target gene |
| 06/22/2005 | CN1630712A Streptomyces avermitilis gene directing the ratio of B2:B1 avermectins |
| 06/22/2005 | CN1630664A Caspase-8 binding protein, its preparation and use |
| 06/22/2005 | CN1630663A Synthetic or natural peptides binding protein phosphatase 2A, identification method and uses |
| 06/22/2005 | CN1630661A Macrolides with antibacterial activity |
| 06/22/2005 | CN1630658A Variolin derivatives as anti-cancer agents |
| 06/22/2005 | CN1630657A Deazapurines and uses thereof |
| 06/22/2005 | CN1630656A Dihydropyrazolopyridine compounds and pharmaceutical use thereof |
| 06/22/2005 | CN1630655A Dual action antibiotics |
| 06/22/2005 | CN1630654A R- - -1- [2- 7-chlorobenzo [b] thiophen-3 -yl- methoxy -2- 2, 4-dichlorophenyl -ethyl] -1h-imidazole |
| 06/22/2005 | CN1630653A Pyrazolyl-substituted heterocycles and their use as phytosanitary products |
| 06/22/2005 | CN1630652A New piperidinyl-alkylamino-pyridazinone derivatives, a process for the preparation thereof and pharmaceutical compositions containing said compounds |
| 06/22/2005 | CN1630651A Novel gamma secretase inhibitors |
| 06/22/2005 | CN1630650A Nitrogenous heterocyclic compound and medicine thereof |
| 06/22/2005 | CN1630649A Dihydrothiaphenanthrenecarbonylguanidines: composition, process of making, and use as medicament or diagnostic aid |
| 06/22/2005 | CN1630648A N－苯基－2－嘧啶胺衍生物 N- phenyl-2-pyrimidine-amine derivative |